文章摘要

参考文献/References

［1］Sadler PJ, Tucker A, Viles JH. Involvement of a lysine residue in the N-terminal Ni2+ and Cu2+ binding site of serum albumins. Comparison with Co2+, Cd2+ and Al3+［J］. Eur J Biochem, 1994, 220(1):193-200.

［2］Roy D, Quiles J, Sinha M, et al. Effect of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin［J］. Am J Cardiol, 2004, 94(2):23423-23426.

［3］Borderie D, Allanore Y, Meune C, et al. High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis［J］. Clin Chem, 2004, 50(11):2190-2193.

［4 Roy D, Quiles J, Gaze DC, et al. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin［J］. Heart, 2006, 92(1):113-114.

［5］Marx G, Chevion M. Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate［J］. Biochem J, 1986, 236(2):397-400.

[6]Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction［J］. Clin Chem, 2003, 49(4):581-585.

[7]Mothes E, Faller P. Evidence that the principal CoII-binding site in human serum albumin is not at the N-terminus: implication on the albumin cobalt binding test for detecting myocardial ischemia［J］. Biochemistry, 2007, 46(8):2267-2274.

[8] Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report［J］. J Emerg Med, 2000, 19(4): 311-315.

[9]Canto JG, Shlipak MG, Rogers WJ, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain［J］. Jama, 2000, 283(24):3223-3229.

[10]Rouan GW, Lee TH, Cook EF, et al. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study)［J］. Am J Cardiol, 1989, 64(18):1087-1092.

[11]Sinha MK, Gaze DC, Tippins JR, et al. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention［J］. Circulation, 2003, 107(19):2403-2405.

[12]Peacock F, Morris DL, Anwaruddin S, et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department［J］. Am Heart J, 2006, 152(2):253-262.

[13]Lee YW, Kim HJ, Cho YH, et al. Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome［J］. Clin Chim Acta, 2007, 384(1-2):24-27.

[14]Quiles J, Roy D, Gaze D, et al. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia［J］. Am J Cardiol, 2003, 92(3):322-324.

[15]Dusek J, Stasek J, Tichy M, et al. Prognostic significance of ischemia modified albumin after percutaneous coronary intervention［J］. Clin Chim Acta, 2006, 367(1-2):77-80.

[16]Roy D, Quiles J, Aldama G, et al. Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T［J］. Int J Cardiol, 2004, 97(2):297-301.

[17]Aparci M, Kardesoglu E, Ozmen N, et al. Prognostic significance of ischemia-modified albumin in patients with acute coronary syndrome［J］. Coron Artery Dis, 2007, 18(5):367-373.

[18]Pollack CV, Peacock FW, Summers RW, et al. Ischemia-modified Albumin (IMA) Is Useful in Risk Stratification of Emergency Department Chest Pain［J］. Acad Emerg Med, 2003, 10(5):555-556.

[19]Keating L, Benger JR, Beetham R, et al. The PRIMA study: presentation ischaemia-modified albumin in the emergency department［J］. Emerg Med J, 2006, 23(10):764-768.

[20]Abboud H, Labreuche J, Meseguer E, et al. Ischemia-modified albumin in acute stroke［J］. Cerebrovasc Dis, 2007, 23(2-3):216-220.

[21]Turedi S, Gunduz A, Mentese A, et al. The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism［J］. Respir Res, 2008, 9:49.

[22]Roy D, Quiles J, Sharma R, et al. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia［J］. Clin Chem, 2004, 50(9):1656-1660.

[23]Apple FS, Quist HE, Otto AP, et al. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race［J］. Clin Chem, 2002, 48(7):1097-1100.

我们的网站为什么显示成这样？

IMA在缺血性疾病诊断中应用的研究进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics